Related references
Note: Only part of the references are listed.Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats
Marzia Pesaresi et al.
HORMONES AND BEHAVIOR (2010)
Sex-specific therapeutic strategies based on neuroactive steroids: In search for innovative tools for neuroprotection
Roberto Cosimo Melcangi et al.
HORMONES AND BEHAVIOR (2010)
Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis
Donatella Caruso et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels
Silvia Giatti et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Neuroprotective actions of sex steroids in Parkinson's disease
Melanie Bourque et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2009)
Progesterone and progestins: neuroprotection and myellin repair
Michael Schumacher et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases
Elisabetta Vegeto et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2008)
Neuroactive steroid levels in a transgenic rat model of CMT1A neuropathy
Donatella Caruso et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Pregnenolone sulfate induces NMDA receptor dependent release of dopamine from synaptic terminals in the striatum
Matthew T. Whittaker et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Nanomolar Concentrations of Pregnenolone Sulfate Enhance Striatal Dopamine Overflow in Vivo
G. Sadri-Vakili et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Estrogen and SERM neuroprotection in animal models of Parkinson's disease
Marc Morissette et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: Effect of diabetes
Donatella Caruso et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
The 6-hydroxydopamine model: News from the past
Fabio Blandini et al.
PARKINSONISM & RELATED DISORDERS (2008)
Neuroactive steroids: State of the art and new perspectives
R. C. Melcangi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system
Michael Schumacher et al.
ENDOCRINE REVIEWS (2007)
Comparative non-radioactive RT-PCR assay: An approach to study the neurosteroids biosynthetic pathway in humans
Sabina Luchetti et al.
JOURNAL OF NEUROSCIENCE METHODS (2006)
Neurosteroids:: Endogenous regulators of the GABAA receptor
D Belelli et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Isoallopregnanolone; an antagonist to the anaesthetic effect of allopregnanolone in male rats
T Bäckström et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease
GE Gillies et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo
I Ciriza et al.
JOURNAL OF NEUROENDOCRINOLOGY (2004)
Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson's disease
F de Michele et al.
NEUROLOGICAL SCIENCES (2003)
Steroids modulate N-methyl-D-aspartate-stimulated [3H]dopamine release from rat striatum via σ receptors
SJ Nuwayhid et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3β-hydroxy-5α-pregnan-20-one (isoallopregnanolone)
P Lundgren et al.
BRAIN RESEARCH (2003)
Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice
AD Ramirez et al.
NEUROENDOCRINOLOGY (2003)
Dehydroepiandrosterone (DHEA) such as 17 beta-estradiol prevents MPTP-induced dopamine depletion in mice
M D'Astous et al.
SYNAPSE (2003)
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case-control study
MD Benedetti et al.
MOVEMENT DISORDERS (2001)
Neuroprotective properties of 17β-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice
S Callier et al.
SYNAPSE (2001)
Molecular characterization of a first human 3(α→β)-hydroxysteroid epimerase
XF Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Functional changes of the basal ganglia circuitry in Parkinson's disease
F Blandini et al.
PROGRESS IN NEUROBIOLOGY (2000)
Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations
KL Tsang et al.
NEUROLOGY (2000)
Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice
M Grandbois et al.
NEUROREPORT (2000)
Share Paper
